Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Astex Pharmaceuticals
h-index: 39
Total citations: 5,485
Total papers: 238
Homepage:
https://astx.com
Recent papers from Astex Pharmaceuticals
Facilitating the identification of cryo-EM hit matter in drug discovery with Astex-Faro
2026
Guest-Programmed Adaptive Redistribution in Heteroleptic Metal–Organic Cages
Journal of the American Chemical Society · 2026
PSQAN: a pipeline to prioritise novel and biologically relevant transcripts from long-read RNA sequencing
Bioinformatics Advances · 2025
Design, Modular Synthesis and Screening of 58 Shape-Diverse 3-D Fragments
2025
Mapping the space of protein binding sites with sequence-based protein language models
Bioinformatics · 2025
Acute Myeloid Leukemia with deletion 5q is an epigenetically distinct subgroup defined by heterozygous loss of KDM3B
2024
Accelerating Fragment Based Drug Discovery using Grand Canonical Nonequilibrium Candidate Monte Carlo
2024
Real‐world study of the use of azacitidine in myelodysplasia in Australia
eJHaem · 2024
Epigenetic priming by hypomethylation enhances the immunogenic potential of tolinapant in T-cell lymphoma
Cancer Research Communications · 2024
Kilo-Scale Synthesis of the Dinucleotide DNA Methyltransferase Inhibitor Guadecitabine
Organic Process Research & Development · 2024
Development of a Kilogram-Scale Manufacturing Route for Bis-Tac-dG: Essential Building-Block for Guadecitabine
Organic Process Research & Development · 2024
Abstract CT066: Phase 1 study of MDM2 antagonist ASTX295 in patients with solid tumors with wild-type TP53
Cancer Research · 2024
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial
Blood Advances · 2024
RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort
Leukemia · 2023
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients
Leukemia · 2023
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
Blood Advances · 2023
Use of Large Language Models and Artificial Intelligence Tools in Works Submitted to Journal of Clinical Oncology
Journal of Clinical Oncology · 2023
Dose‐escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF‐mutant solid tumors
Cancer · 2023
SMAC Mimetics Synergistically Cooperate with HDAC Inhibitors Enhancing TNF-α Autocrine Signaling
Cancers · 2023
Accelerated Chemical Reaction Optimization using Multi-Task Learning
2023